News

Article

Novartis, ASCP, and ACS Partner for African Cancer Initiative

The entities announced that they will partner to improve access to cancer treatments and diagnostics in Ethiopia, Uganda, and Tanzania.

On Nov. 15, 2017, Novartis announced a partnership with the American Society for Clinical Pathology (ASCP) and the American Cancer Society (ACS) to improve access to cancer treatments and diagnostics in Sub-Saharan Africa (Ethiopia, Uganda, and Tanzania).

Under the terms of the partnership, Novartis will fund the technical work associated with the initiative. ASCP will take on the diagnostic aspect, expanding healthcare capacity for immuno-histochemistry (IHC) analysis in two hospital laboratories in Ethiopia and Tanzania under its IHC Capacity Building Program. ACS will support training of healthcare professionals in biopsy sample transport and chemotherapy application in all three nations under its ChemoSafe Program. According to Novartis, Sub-Saharan Africa is only the first focus of the partnership.

"Immunohistochemistry is required for oncologists to treat many cancers," said ASCP CEO Blair Holladay, PhD, in a company press release. “This partnership will allow us to provide high-quality, rapid, and accurate screening and diagnosis, taking in-country cancer care to the next level."

"A medicine is only as good as the system that delivers it," said Dr. Harald Nusser, head of Novartis Social Business. "Through our catalytic funding, we target projects that have an impact on healthcare providers and support patients through their journey. We hope this collaboration will provide earlier and more effective diagnosis to cancer patients, improving the likelihood for better health outcomes."

Source: Novartis

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content